Vericel Corp
SWB:ATQP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Vericel Corp (ATQP) under the Base Case is EUR per share.
Compared with the current market price of 48.8 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Vericel Does
Vericel Corp makes and sells specialty cell-therapy products for difficult orthopedic and burn injuries. Its main products are used by surgeons and hospitals to treat damaged knee cartilage and severe burns, where standard treatments may not work as well. The company focuses on very specific medical problems instead of broad drug categories.
- Headquarters
- United States of America US
- Employees
- 398
- IPO date
- Feb 4, 1997
Revenue & Expenses Breakdown
Vericel Corp
Earnings Waterfall
Vericel Corp
What is the Intrinsic Value of one ATQP stock?
The intrinsic value for Vericel Corp (ATQP) under the Base Case is EUR.
Is ATQP stock undervalued or overvalued?
Compared with the current market price of 48.8 EUR, the stock appears .
